Yuan, Jin-Qiu <br/><br/>
EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.  [electronic resource] 

 -  Medicine  Feb 2017 
 - e6151 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-5964 
<br/><br/><label>Standard No.: </label>10.1097/MD.0000000000006151  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--blood<br/>Hematologic Tests<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Protein Kinase Inhibitors--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Survival Analysis<br/>Systematic Reviews as Topic<br/>Meta-Analysis as Topic